unknown
Stage
2020
Founded
1
Investors
About
Adcendo is a biotech company developing a new generation of antibody-drug conjugates (ADCs) to address cancers with high unmet medical need, advancing innovative oncology programs from discovery through clinical development.
Explore Adcendo ApS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.